Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti‐Inflammatory Drugs is a research paper published in Clinical Pharmacology & Therapeutics (2020). On theSindex it has a DataRank of 0. It has been cited 333 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R24GM115264
National Institutes of Health
Grant: U24HG010135
National Institutes of Health
Grant: R24GM61374
National Institutes of Health
Grant: U24HG010615
NIGMS NIH HHS
Grant: R24 GM061374
NIGMS NIH HHS
Grant: R24 GM123930
National Institutes of Health
Grant: 5U24HG010135-03
Clinical Pharmacogenetics Implementation Consortium (CPIC)
National Institutes of Health
Grant: 5R24GM061374-13
PharmGKB: From Association to Mechanism
National Institutes of Health
Grant: 1R24GM115264-01
Clinical Pharmacogenetics Implementation Consortium (CPIC)
National Institutes of Health
Grant: 5R24GM123930-03
PHARMacogene VARiation Consortium
FWCI
35.26
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals